Related Experiment Video

Updated: Aug 18, 2025

Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology
06:19

Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology

Published on: May 31, 2024

936

[Ophtalmological adverse events related to immune checkpoint inhibitors]

A Vanderperren1,2, C Pirard3,4, G Lepièce2

  • 1Service d'Ophtalmologie CHU Liège, Belgique.

Revue Medicale De Liege
|December 9, 2022
PubMed

Insights

Immune checkpoint inhibitors (ICIs) can cause ocular side effects. Early detection and management by healthcare providers are crucial for preserving vision and continuing cancer therapy.

Area of Science:

  • Oncology
  • Immunology
  • Ophthalmology

Context:

  • Immune checkpoint inhibitors (ICIs) are vital in cancer treatment.
  • ICIs can lead to immune-related adverse events affecting the eyes.
  • Ophthalmological side effects can impact patient prognosis and treatment continuation.

Purpose:

  • To outline the primary ocular side effects of ICIs.
  • To provide a management strategy for these side effects.
  • To emphasize the importance of early detection and patient education.

Summary:

  • ICIs, while effective against cancer, present unique ophthalmological challenges.
  • Common ocular side effects include [specific examples if available in abstract].
  • Prompt recognition and intervention are key to managing these adverse events.

Impact:

  • Facilitates timely diagnosis and treatment of ICI-induced ocular toxicity.
  • Aims to minimize visual morbidity and maintain treatment efficacy.
  • Supports the continuation of life-prolonging cancer therapies.
Keywords:
ImmuneOphthalmolgyImmune checkpoint inhibitorsrelated adverse effects

More Related Videos

Induction of Ocular Surface Inflammation and Collection of Involved Tissues06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

2.4K
Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats06:30

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

Published on: May 23, 2025

288

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
520
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
680
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
613